Heart failure drug study pulled before starting
NCT ID NCT06708611
First seen Apr 29, 2026 · Last updated May 16, 2026 · Updated 3 times
Summary
This study aimed to compare an extended-release version of the water pill torsemide to the standard immediate-release version in people with stable heart failure. Researchers planned to measure how much salt the body gets rid of after taking each type. However, the study was withdrawn before enrolling any participants, so no results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Future Life Clinical Trials
Miami, Florida, 33169, United States
Conditions
Explore the condition pages connected to this study.